Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Neurology

Journal Scan / Research · July 17, 2023

Safety and Effectiveness of 5 Years of Treatment With Dimethyl Fumarate in Black and Hispanic Patients With MS

Neurology and Therapy


Additional Info

Disclosure statements are available on the authors' profiles:

Neurology and Therapy
Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM
Neurol Ther 2023 Jun 24;[EPub Ahead of Print], MJ Williams, L Amezcua, A Chinea, S Cohan, A Okai, DT Okuda, W Vargas, N Belviso, I Božin, X Jiang, JB Lewin, J Lyons, C Shen, SM England, N Grimes

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading